Exagen (XGN) EBITDA Margin (2018 - 2026)
Exagen's (XGN) quarterly EBITDA Margin came in at 19.73% in Q1 2026, up 199.0% YoY from 6.6% in Q1 2025, and up 34.05% on a QoQ basis from 29.91% in Q4 2025.
Exagen (XGN) EBITDA Margin (2018 - 2026) Analysis & Trends
Exagen (XGN) has 9 years of EBITDA Margin data on file, last reported at 19.73% in Q1 2026.
- Quarterly EBITDA Margin rose 199.0% year-over-year to 19.73% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.65% (up 403.0% YoY) and the FY2025 annual result came in at 21.13%, up 337.0% from the prior year.
- EBITDA Margin improved to 19.73% in Q1 2026, from 29.91% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 15.29% in Q2 2025 to a low of 184.91% in Q2 2022.
- A 5-year average of 48.66% and a median of 34.77% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 13995 bps — and 2023, when it soared 15014 bps.
- Tracing XGN's EBITDA Margin over 5 years: stood at 112.88% in 2022, then surged by 67 bps to 37.39% in 2023, then jumped by 34 bps to 24.77% in 2024, then retreated by 21 bps to 29.91% in 2025, then jumped by 34 bps to 19.73% in 2026.
- The last three EBITDA Margin figures came in at 19.73% (Q1 2026), 29.91% (Q4 2025), and 17.98% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Exagen | 158.28 Mn | 133.68 Mn | 12.22 Mn | -8.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.64% |
| Mar 31, 2026 | -19.73% |
| Dec 31, 2025 | -29.91% |
| Sep 30, 2025 | -17.98% |
| Jun 30, 2025 | -15.29% |
| Mar 31, 2025 | -21.71% |
| Dec 31, 2024 | -24.77% |
| Sep 30, 2024 | -37.28% |
| Jun 30, 2024 | -17.17% |
| Mar 31, 2024 | -20.83% |
| Dec 31, 2023 | -37.39% |
| Sep 30, 2023 | -37.78% |
| Jun 30, 2023 | -34.77% |
| Mar 31, 2023 | -68.62% |
| Dec 31, 2022 | -112.88% |
| Sep 30, 2022 | -53.08% |
| Jun 30, 2022 | -184.91% |
| Mar 31, 2022 | -93.12% |
| Dec 31, 2021 | -49.29% |
| Sep 30, 2021 | -53.09% |